SCHEMBL20204851

SCHEMBL20204851

O=C(C=S)N1CC2(CC2)OC2(CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21561681 0.62 CA12 (0.54) —
SCHEMBL20204913 0.62 SMN1; SMN2 (0.34) —
SCHEMBL21561651 0.58 PDK1 (0.48) —
SCHEMBL21561662 0.58 PDK1 (0.48) —
SCHEMBL21561685 0.58 TDP1 (0.52) —
SCHEMBL20204916 0.54 CA12 (0.32) —
SCHEMBL12076093 0.54 CHRM2 (0.32) —
SCHEMBL22753531 0.52 TET3 (0.38) —
SCHEMBL22833078 0.49 KMT2A (0.36) —
SCHEMBL1803797 0.45 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098473-A1 REAGENTS AND METHODS FOR ANALYSIS OF PROTEINS AND METABOLITES TARGETED BY COVALENT PROBES DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 — — WO disclosed
Send feedback